Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of tumors that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. The mainstay of treatment remains chemotherapy, but the therapeutic outcome remains inadequate. This paper investigates the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Deeb, Ibrahim M., Pittala, Valeria, Eltayeb, Diab, Greish, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227162/
https://www.ncbi.nlm.nih.gov/pubmed/34207832
http://dx.doi.org/10.3390/molecules26123532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227162/
https://www.ncbi.nlm.nih.gov/pubmed/34207832
http://dx.doi.org/10.3390/molecules26123532

Ejemplares similares